Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 11.3% – Still a Buy?

Posted by on May 22nd, 2026

Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s share price was up 11.3% during mid-day trading on Friday . The stock traded as high as $34.96 and last traded at $33.6550. Approximately 16,692 shares were traded during trading, a decline of 63% from the average daily volume of 44,863 shares. The stock had previously closed at $30.25.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

View Our Latest Research Report on Anbio Biotechnology

Anbio Biotechnology Trading Up 15.4%

The stock has a 50-day moving average price of $26.01.

Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) last released its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

(Get Free Report)

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.

Read More

Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.